Tower Research Capital LLC (Trc) Axsome Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,573 shares of AXSM stock, worth $474,768. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,573
Previous 642
612.31%
Holding current value
$474,768
Previous $57,000
577.19%
% of portfolio
0.01%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding AXSM
# of Institutions
354Shares Held
36.3MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$421 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$405 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$343 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$153 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$144 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.45B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...